Intensive therapies in follicular non-Hodgkin lymphomas

被引：44

作者：

Hunault-Berger, M

Ifrah, N

Solal-Celigny, P

机构：

[1] Ctr Jean Bernard, F-72000 Le Mans, France

[2] Ctr Hosp Univ, Serv Malad Sang, Angers, France

来源：

BLOOD | 2002年 / 100卷 / 04期

关键词：

D O I：

10.1182/blood.V100.4.1141.h81602001141_1141_1152

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1141 / 1152

页数：12

相关论文

共 200 条

[91]

JOHNSON RE, 1978, CANCER TREAT REP, V62, P321

[92] T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: clinical and molecular follow-up [J].

Juckett, M ;

Rowlings, P ;

Hessner, M ;

Keever-Taylor, C ;

Burns, W ;

Camitta, B ;

Casper, J ;

Drobyski, WR ;

Hanson, G ;

Horowitz, M ;

Lawton, C ;

Margolis, J ;

Peitryga, D ;

Vesole, D .

BONE MARROW TRANSPLANTATION, 1998, 21 (09) :893-899

[93] Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma:: updated results and long-term follow-up of the University of Michigan experience [J].

Kaminski, MS ;

Estes, J ;

Zasadny, KR ;

Francis, IR ;

Ross, CW ;

Tuck, M ;

Regan, D ;

Fisher, S ;

Gutierrez, J ;

Kroll, S ;

Stagg, R ;

Tidmarsh, G ;

Wahl, RL .

BLOOD, 2000, 96 (04) :1259-1266

[94] Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease:: a clinical and molecular analysis [J].

Kanteti, R ;

Miller, KB ;

McCann, JC ;

Roitman, D ;

Morelli, J ;

Hurley, C ;

Berkman, E ;

Schenkein, DP .

BONE MARROW TRANSPLANTATION, 1999, 24 (05) :473-481

[95]

Kessinger A, 1998, CANCER RES THER CONT, V5, P113

[96] Transplant-lite:: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor cell transplantation as treatment for lymphoid malignancies [J].

Khouri, IF ;

Keating, M ;

Körbling, M ;

Przepiorka, D ;

Anderlini, P ;

O'Brien, S ;

Giralt, S ;

Ippoliti, C ;

von Wolff, B ;

Gajewski, J ;

Donato, M ;

Claxton, D ;

Ueno, N ;

Andersson, B ;

Gee, A ;

Champlin, R .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2817-2824

[97] Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality [J].

Khouri, IF ;

Saliba, RM ;

Giralt, SA ;

Lee, MS ;

Okoroji, GJ ;

Hagemeister, FB ;

Korbling, M ;

Younes, A ;

Ippoliti, C ;

Gajewski, JL ;

McLaughlin, P ;

Anderlini, P ;

Donato, ML ;

Cabanillas, FF ;

Champlin, RE .

BLOOD, 2001, 98 (13) :3595-3599

[98] DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma [J].

King, CA ;

Spellerberg, MB ;

Zhu, DL ;

Rice, J ;

Sahota, SS ;

Thompsett, AR ;

Hamblin, TJ ;

Radl, J ;

Stevenson, FK .

NATURE MEDICINE, 1998, 4 (11) :1281-1286

[99]

KLINGEMANN HG, 1991, BLOOD, V78, P3306

[100] Peripheral blood stem cell versus bone marrow allotransplantation:: does the source of hematopoietic stem cells matter? [J].

Körbling, M ;

Anderlini, P .

BLOOD, 2001, 98 (10) :2900-2908

← 5 6 7 8 9 10 11 12 13 14 →